ArticlePloS one2024
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma.
Yibo Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticlePloS one2024
Yibo Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.